Drug Information

General Information
Drug ID
DR00590
Drug Name
Trimethoprim
Synonyms
AZT + TMP/SMX (mixture) combination; Abaprim; Alcorim-F; Alprim; Anitrim; Antrima; Antrimox; Apo-Sulfatrim; BW 56-72; BW 5672; BW-56-72; Bacdan; Bacidal; Bacide; Bacin; Bacta; Bacterial; Bacterial [Antibiotic]; Bacticel; Bactin; Bactoprim; Bactramin; Bencole; Bethaprim; Biosulten; Briscotrim; Chemotrin; Cidal; Co-Trimoxizole; Colizole; Colizole DS; Component of Bactrim; Component of Septra; Conprim; Cotrimel; Deprim; Duocide; Esbesul; Espectrin; Euctrim; Exbesul; Fermagex; Fortrim; Futin; Idotrim; Ikaprim; Instalac; KSC-4-158; KUC103659N; Kombinax; Lagatrim; Lagatrim Forte; Lastrim; Methoprim; Metoprim; Monoprim; Monotrim; Monotrim (TN); Monotrimin; NIH 204; NIH 204 (VAN); Novotrimel; Omstat; Oraprim; Pancidim; Polytrim; Priloprim; Primosept; Primsol; Proloprim; Proloprim (TN); Protrin; Purbal; Resprim; ResprimForte; Roubac; Roubal; Salvatrim; Septrin DS; Septrin Forte; Septrin S; Setprin; Sinotrim; Smz-Tmp; Stopan; Streptoplus; Sugaprim; Sulfamar; Sulfamethoprim; Sulfamethoxazole & Trimethoprim; Sulfoxaprim; Sulmeprim; Sulthrim; Sultrex; Syraprim; T 7883; TCMDC-125538; TMP; TMP/SMX (MIXTURE)); Tiempe; Tmp-Ratiopharm; Toprim; Trimanyl; Trimeth/Sulfa; Trimethioprim; Trimethopim(TMP); Trimethoprim & VRC3375; Trimethoprim (JAN/USP/INN); Trimethoprim [USAN:BAN:INN:JAN]; Trimethoprime; Trimethoprime [INN-French]; Trimethoprimum; Trimethoprimum [INN-Latin]; Trimethopriom; Trimetoprim; Trimetoprim [DCIT]; Trimetoprim [Polish]; Trimetoprima; Trimetoprima [INN-Spanish]; Trimexazole; Trimexol; Trimez-IFSA; Trimezol; Trimogal; Trimono; Trimopan; Trimpex; Trimpex (TN); Trimpex 200; Triprim; Triprim (TN); Trisul; Trisulcom; Trisulfam; Trisural; U-Prin; Uretrim; Uro-D S; Urobactrim; Utetrin; Velaten; WR 5949; Wellcoprim; Wellcoprin; Xeroprim; Zamboprim
Drug Type
Small molecular drug
Indication Urinary tract infections [ICD11: GC08] Approved [1]
Therapeutic Class
Antiinfective Agents
Structure
3D MOL 2D MOL
Formula
C14H18N4O3
Canonical SMILES
COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
InChI
InChI=1S/C14H18N4O3/c1-19-10-5-8(6-11(20-2)12(10)21-3)4-9-7-17-14(16)18-13(9)15/h5-7H,4H2,1-3H3,(H4,15,16,17,18)
InChIKey
IEDVJHCEMCRBQM-UHFFFAOYSA-N
CAS Number
CAS 738-70-5
Pharmaceutical Properties Molecular Weight 290.32 Topological Polar Surface Area 106
Heavy Atom Count 21 Rotatable Bond Count 5
Hydrogen Bond Donor Count 2 Hydrogen Bond Acceptor Count 7
XLogP
0.9
PubChem CID
5578
PubChem SID
10321479 , 10534335 , 11111923 , 11111924 , 11113621 , 11335764 , 11361003 , 11363061 , 11365623 , 11368185 , 11371565 , 11374002 , 11376347 , 11461975 , 11466236 , 11467356 , 11484610 , 11485852 , 11488753 , 11490459 , 11492187 , 11493981 , 14824824 , 17389524 , 17405825 , 22391545 , 24278201 , 24870616 , 24889615 , 25623645 , 26611964 , 26680042 , 26697109 , 26704777 , 26747124 , 26747125 , 26751820 , 3146445 , 406777 , 4752045 , 5066 , 604810 , 7847213 , 7890832 , 7980835 , 8027414 , 8149571 , 8153433 , 837167 , 857743
ChEBI ID
ChEBI:45924
TTD Drug ID
D0AO5H
DT(s) Transporting This Drug OCT-1 Transporter Info Organic cation transporter 1 Substrate [2]
P-GP Transporter Info P-glycoprotein 1 Substrate [3]
References
1 Trimethoprim was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Identification of novel substrates and structure-activity relationship of cellular uptake mediated by human organic cation transporters 1 and 2. J Med Chem. 2013 Sep 26;56(18):7232-42.
3 Improving the prediction of the brain disposition for orally administered drugs using BDDCS. Adv Drug Deliv Rev. 2012 Jan;64(1):95-109.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.